Hitoshi Ohtani

2.2k total citations · 1 hit paper
32 papers, 1.6k citations indexed

About

Hitoshi Ohtani is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Hitoshi Ohtani has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Immunology and 7 papers in Genetics. Recurrent topics in Hitoshi Ohtani's work include HIV Research and Treatment (5 papers), Epigenetics and DNA Methylation (5 papers) and Chromosomal and Genetic Variations (4 papers). Hitoshi Ohtani is often cited by papers focused on HIV Research and Treatment (5 papers), Epigenetics and DNA Methylation (5 papers) and Chromosomal and Genetic Variations (4 papers). Hitoshi Ohtani collaborates with scholars based in Japan, United States and Denmark. Hitoshi Ohtani's co-authors include Peter A. Jones, Daniel D. De Carvalho, Ankur Chakravarthy, Minmin Liu, Gangning Liang, Wanding Zhou, Akinori Kimura, Yuka W. Iwasaki, Mikiko C. Siomi and Stephen B. Baylin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Genes & Development.

In The Last Decade

Hitoshi Ohtani

32 papers receiving 1.5k citations

Hit Papers

Epigenetic therapy in immune-oncology 2019 2026 2021 2023 2019 100 200 300

Peers

Hitoshi Ohtani
Peter Bugert Germany
Judy A. Mietz United States
Jasper H. N. Yik United States
Sarah H. Johnson United States
V L Morris Canada
David Steiner United States
Hitoshi Ohtani
Citations per year, relative to Hitoshi Ohtani Hitoshi Ohtani (= 1×) peers David Roulois

Countries citing papers authored by Hitoshi Ohtani

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Ohtani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Ohtani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Ohtani more than expected).

Fields of papers citing papers by Hitoshi Ohtani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Ohtani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Ohtani. The network helps show where Hitoshi Ohtani may publish in the future.

Co-authorship network of co-authors of Hitoshi Ohtani

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Ohtani. A scholar is included among the top collaborators of Hitoshi Ohtani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Ohtani. Hitoshi Ohtani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishiguro, Kazuya, Hiroshi Kitajima, Takeshi Niinuma, et al.. (2021). Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis. Cell Death Discovery. 7(1). 7–7. 54 indexed citations
2.
Ohtani, Hitoshi, Andreas Due Ørskov, Linn Gillberg, et al.. (2020). Activation of a Subset of Evolutionarily Young Transposable Elements and Innate Immunity Are Linked to Clinical Responses to 5-Azacytidine. Cancer Research. 80(12). 2441–2450. 36 indexed citations
3.
Ishizu, Hirotsugu, et al.. (2019). Armitage determines Piwi−piRISC processing from precursor formation and quality control to inter‐organelle translocation. EMBO Reports. 21(2). e48769–e48769. 20 indexed citations
4.
Gillberg, Linn, Andreas Due Ørskov, Ammar Nasif, et al.. (2019). Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: Normalization of plasma vitamin C induces epigenetic changes. Clinical Epigenetics. 11(1). 143–143. 58 indexed citations
5.
Liu, Minmin, Stacey L. Thomas, Wanding Zhou, et al.. (2018). Dual Inhibition of DNA and Histone Methyltransferases Increases Viral Mimicry in Ovarian Cancer Cells. Cancer Research. 78(20). 5754–5766. 85 indexed citations
6.
Liu, Minmin, Lian Zhang, Hongtao Li, et al.. (2018). Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI‐110) in Hepatocellular Carcinoma. Hepatology. 68(4). 1412–1428. 49 indexed citations
7.
Ohtani, Hitoshi, Minmin Liu, Wanding Zhou, Gangning Liang, & Peter A. Jones. (2018). Switching roles for DNA and histone methylation depend on evolutionary ages of human endogenous retroviruses. Genome Research. 28(8). 1147–1157. 87 indexed citations
8.
Liu, Minmin, Hitoshi Ohtani, Wanding Zhou, et al.. (2016). Vitamin C increases viral mimicry induced by 5-aza-2′-deoxycytidine. Proceedings of the National Academy of Sciences. 113(37). 10238–10244. 150 indexed citations
9.
Sakurai, Daisuke, Yasumasa Iwatani, Hitoshi Ohtani, et al.. (2015). APOBEC3H polymorphisms associated with the susceptibility to HIV-1 infection and AIDS progression in Japanese. Immunogenetics. 67(4). 253–257. 15 indexed citations
10.
Ohtani, Hitoshi, Yuka W. Iwasaki, Aoi Shibuya, et al.. (2013). DmGTSF1 is necessary for Piwi–piRISC-mediated transcriptional transposon silencing in the Drosophila ovary. Genes & Development. 27(15). 1656–1661. 116 indexed citations
11.
Ohtani, Hitoshi, Taeko K. Naruse, Yuki Iwasaki, et al.. (2012). Lineage-specific evolution of T-cell immunoglobulin and mucin domain 1 gene in the primates. Immunogenetics. 64(9). 669–678. 6 indexed citations
12.
Sharma, Gaurav, Hitoshi Ohtani, Gurvinder Kaur, et al.. (2012). Status of TIM-1 exon 4 haplotypes and CD4+T cell counts in HIV-1 seroprevalent North Indians. Human Immunology. 74(2). 163–165. 5 indexed citations
13.
Ohtani, Hitoshi, Hiromichi Wakui, Atsushi Komatsuda, et al.. (2010). Progressive glomerulopathy with unusual deposits of striated structures: a new disease entity?. Nephrology Dialysis Transplantation. 25(6). 2016–2019. 8 indexed citations
14.
Wichukchinda, Nuanjun, Toshiaki Nakajima, Emi E. Nakayama, et al.. (2010). TIM1 haplotype may control the disease progression to AIDS in a HIV-1-infected female cohort in Thailand. AIDS. 24(11). 1625–1631. 17 indexed citations
15.
Hinohara, Kunihiko, Hitoshi Ohtani, Toshiaki Nakajima, et al.. (2009). Validation of eight genetic risk factors in East Asian populations replicated the association of BRAP with coronary artery disease. Journal of Human Genetics. 54(11). 642–646. 14 indexed citations
16.
Nakajima, Toshiaki, Emi E. Nakayama, Gurvinder Kaur, et al.. (2009). Impact of novel TRIM5α variants, Gly110Arg and G176del, on the anti-HIV-1 activity and the susceptibility to HIV-1 infection. AIDS. 23(16). 2091–2100. 25 indexed citations
17.
Nakajima, Toshiaki, Hitoshi Ohtani, Yoko Satta, et al.. (2008). Natural selection in the TLR-related genes in the course of primate evolution. Immunogenetics. 60(12). 727–735. 52 indexed citations
18.
Nakajima, Toshiaki, Hitoshi Ohtani, Taeko K. Naruse, et al.. (2007). Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia. Immunogenetics. 59(10). 793–798. 31 indexed citations
19.
Komatsuda, Atsushi, Rie Masai, Hiromichi Wakui, et al.. (2006). Analysis of the NPHP genes in two Japanese patients with suspected sporadic juvenile or adolescent nephronophthisis. Clinical Nephrology. 65(5). 364–369. 3 indexed citations
20.
Maki, Nobuki, Atsushi Komatsuda, Hiromichi Wakui, et al.. (2004). A nonsense mutation (R220X) in the a-galactosidase A gene causes typical Fabry disease in both genders. Clinical Nephrology. 61(3). 185–190. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026